RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Toxicity studies of trans-resveratrol administered by gavage for two weeks or three months to F344/NTac rats, Wistar Han [Crl:WI(Han)] rats, and B6C3F1/N mice
Huang, M. C., Elmore, S. A., Adams, E. T., Black, W. M., Blake, J. C., Blystone, C. R., Burback, B., Carrico, K. A., Colleton, C. A., Collins, B. J., Contos, D. A., Cooper, S. D., Cora, M. C., Dalefield, R. R., Fernando, R., Fomby, L. M., Fostel, J. M., Germolec, D., Hejtmancik, M. R., ... Witt, K. L. (2021). Toxicity studies of trans-resveratrol administered by gavage for two weeks or three months to F344/NTac rats, Wistar Han [Crl:WI(Han)] rats, and B6C3F1/N mice. (102 ed.) National Toxicology Program, NIEHS. Toxicity Report Series No. 102 https://doi.org/10.22427/NTP-TOX-102
Trans-resveratrol (RES) is a polyphenol found in various fruits and plants. Numerous in vitro studies have shown its clear antioxidant and anti-inflammatory effects, which has led to additional in vivo and clinical studies evaluating the use of RES to treat diseases such as cancer, cardiometabolic disease, and neurodegenerative disease. Despite growing interest in and use of RES, limited studies have assessed the safety of RES exposure, especially perinatally. The National Toxicology Program conducted toxicity studies to provide these data. (Abstract Abridged).
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.
